1
High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
Condition(s):MelanomaLast Updated:February 19, 2020Completed
Hide Studies Not Open or Pending
Condition(s):MelanomaLast Updated:February 19, 2020Completed
Condition(s):MelanomaLast Updated:April 4, 2016Completed
Condition(s):MelanomaLast Updated:December 20, 2019Terminated
Condition(s):Bladder CancerLast Updated:February 4, 2015Completed
Condition(s):Urinary Bladder NeoplasmsLast Updated:January 9, 2019Terminated
Condition(s):Multiple MyelomaLast Updated:October 25, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.